A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: Design of the OPTIMA trial

Osteoporosis International

Volumn 21, Issue 1, 2010, Pages 137-144

  Solomon, D H ^a   Gleeson, T ^a   Iversen, M ^a   Avorn, J ^a   Brookhart, M A ^a   Lii, J ^a   Losina, E ^a   May, F ^a   Patrick, A ^a   Shrank, W H ^a   Katz, J N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Education; Medication adherence; Osteoporosis; Randomized controlled trial

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; IBANDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN ENDED QUESTIONNAIRE; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCRIPTION; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; COUNSELING; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MOTIVATION; OSTEOPOROSIS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; REMOTE CONSULTATION; RESEARCH DESIGN; SINGLE-BLIND METHOD; TELEPHONE;

EID: 72449133832     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0951-9     Document Type: Article

References (25)

1. RL Wolf JM Zmuda KL Stone JA Cauley 2000 Update on the epidemiology of osteoporosis Curr Rheumatol Rep 2 1 74 86 10.1007/s11926-996-0072-9 1:STN:280:DC%2BD3M7ktVWqsg%3D%3D 11123043
2. RS Braithwaite NF Col JB Wong 2003 Estimating hip fracture morbidity, mortality and costs J Am Geriatr Soc 51 3 364 370 10.1046/j.1532-5415.2003. 51110.x 12588580 (Pubitemid 36348898)
3. AN Tosteson LJ Melton 3rd B Dawson-Hughes, et al. 2008 Cost-effective osteoporosis treatment thresholds: the United States perspective Osteoporos Int 19 4 437 447 10.1007/s00198-007-0550-6 1:STN:280:DC%2BD1c7nvF2ntg%3D%3D 18292976
4. RD-HB Burge DH Solomon JB Wong A King A Tosteson 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 3 465 475 10.1359/jbmr.061113 17144789 (Pubitemid 46797130)
5. A Cranney G Guyatt L Griffith, et al. 2002 Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr Rev 23 4 570 578 10.1210/er.2001-9002 1:CAS:528:DC%2BD38Xnt1Whs78%3D 12202472 (Pubitemid 34925651)
6. AM Peterson DP Nau JA Cramer J Benner F Gwadry-Sridhar M Nichol 2007 A checklist for medication compliance and persistence studies using retrospective databases Value Health 10 1 3 12 10.1111/j.1524-4733.2006.00139.x 17261111 (Pubitemid 46161090)
7. P Kothawala E Badamgarav S Ryu RM Miller RJ Halbert 2007 Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Mayo Clin Proc 82 12 1493 1501 10.4065/82.12.1493 18053457
8. DH Solomon J Avorn JN Katz, et al. 2005 Compliance with osteoporosis medications Arch Intern Med 165 20 2414 2419 10.1001/archinte.165.20.2414 16287772 (Pubitemid 41640855)
9. JR Curtis AO Westfall H Cheng K Lyles KG Saag E Delzell 2008 Benefit of adherence with bisphosphonates depends on age and fracture type: results from an analysis of 101,038 new bisphosphonate users J Bone Miner Res 23 9 1435 1441 10.1359/jbmr.080418 18442318
10. CA McHorney JT Schousboe RR Cline TW Weiss 2007 The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates Curr Med Res Opin 23 12 3137 3152 10.1185/030079907X242890 1:CAS:528:DC%2BD1cXhslOktr0%3D 17988435
11. JA Cramer DT Gold SL Silverman EM Lewiecki 2007 A systematic review of persistence and compliance with bisphosphonates for osteoporosis Osteoporos Int 18 8 1023 1031 10.1007/s00198-006-0322-8 1:CAS:528:DC%2BD2sXntVOlsrY%3D 17308956 (Pubitemid 47019996)
12. JA Clowes NF Peel R Eastell 2004 The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial J Clin Endocrinol Metab 89 3 1117 1123 10.1210/jc.2003-030501 1:CAS:528:DC%2BD2cXisVWrtbo%3D 15001596 (Pubitemid 38368399)
13. PD Delmas B Vrijens R Eastell, et al. 2007 Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis J Clin Endocrinol Metab 92 4 1296 1304 10.1210/jc.2006-1526 1:CAS:528:DC%2BD2sXksVSrsbc%3D 17244788 (Pubitemid 46556401)
14. M Guilera M Fuentes M Grifols J Ferrer X Badia 2006 Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study Osteoporos Int 17 5 664 671 10.1007/s00198-005-0031-8 1:STN:280: DC%2BD28zotlGntw%3D%3D 16437191
15. PF Cook S Emiliozzi MM McCabe 2007 Telephone counseling to improve osteoporosis treatment adherence: an effectiveness study in community practice settings Am J Med Qual 22 6 445 456 10.1177/1062860607307990 18006425
16. A Cooper J Drake E Brankin 2006 Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study Int J Clin Pract 60 8 896 905 10.1111/j.1742-1241.2006.01059.x 1:CAS:528:DC%2BD28XpvVemsLg%3D 16800837 (Pubitemid 44082279)
17. N Heather S Rollnick A Bell R Richmond 1996 Effects of brief counselling among male heavy drinkers identified on general hospital wards Drug Alcohol Rev 15 1 29 38 10.1080/09595239600185641 1:STN:280:DC%2BD2MrivVyqtQ%3D%3D 16203349
18. WR Miller 1996 Motivational interviewing: research, practice, and puzzles Addict Behav 21 6 835 842 10.1016/0306-4603(96)00044-5 1:STN:280: DyaK2s%2FmtV2jsw%3D%3D 8904947 (Pubitemid 26330619)
19. SC Reid M Teesson C Sannibale M Matsuda PS Haber 2005 The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: a randomized controlled trial J Stud Alcohol 66 6 833 841 16459945
20. JH Samet NJ Horton S Meli, et al. 2005 A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems Antivir Ther 10 1 83 93 1:CAS:528:DC%2BD2MXis1Kmtb4%3D 15751766
21. G Ogedegbe A Schoenthaler T Richardson, et al. 2007 An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design Contemp Clin Trials 28 2 169 181 10.1016/j.cct.2006.04.002 16765100 (Pubitemid 44940916)
22. C DiIorio F McCarty K Resnicow, et al. 2008 Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study AIDS Care 20 3 273 283 10.1080/09540120701593489 1:STN:280:DC%2BD1c7ptlyqsw%3D%3D 18351473
23. MC Nevitt SR Cummings WS Browner, et al. 1992 The accuracy of self-report of fractures in elderly women: evidence from a prospective study Am J Epidemiol 135 5 490 499 1:STN:280:DyaK383jvVCltA%3D%3D 1570815
24. RQ Ivers RG Cumming P Mitchell AJ Peduto 2002 The accuracy of self-reported fractures in older people J Clin Epidemiol 55 5 452 457 10.1016/S0895-4356(01)00518-2 12007547 (Pubitemid 34462240)
25. Haynes RB, Yao X, Degani A, Kripalani S, Garg A, McDonald HP (2005) Interventions to enhance medication adherence. Cochrane Database Syst Rev (4):CD000011